BIDMC-led Trial Leads to FDA approval of Coronary Drug-coated Balloons
DAIC
MARCH 13, 2024
suggest that the drug-coated balloon offers an effective treatment strategy for the management of coronary in-stent restenosis, or blockages recurring within previously placed stents. Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC.
116 
Let's personalize your content